AVITA Medical Inc reports results for the quarter ended December 31 - Earnings Summary

• AVITA Medical Inc RCEL.OQ reported a quarterly adjusted loss of 44 cents​​ per share for the quarter ended December 31, lower than the same quarter last year, when the company reported EPS of -28 cents. The mean expectation of seven analysts for the quarter was for a loss of 43 cents per share. Wall Street expected results to range from -61 cents to -20 cents per share.

• Revenue rose 29.7% to $18.41 million from a year ago; analysts expected $21.04 million.

• AVITA Medical Inc's reported EPS for the quarter was a loss of 44 cents​.

• The company reported a quarterly loss of $11.59 million.

• AVITA Medical Inc shares had fallen by 32.7% this quarter.

FORECAST CHANGES

• The mean earnings estimate of analysts had fallen by about 21.3% in the last three months.​

• In the last 30 days, one analyst negatively revised an earnings estimate

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 5 "strong buy" or "buy," 3 "hold" and no "sell" or "strong sell."

• The average consensus recommendation for the biotechnology & medical research peer group is also "buy"

Wall Street's median 12-month price target for AVITA Medical Inc is $15.00

This summary was machine generated from LSEG data February 13 at 11:29 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)